Document is current
Any future updates will be listed below
-
Authors
Lempp, Florian A. https://orcid.org/0000-0001-6103-8078
Soriaga, Leah B. https://orcid.org/0000-0001-5852-741X
Montiel-Ruiz, Martin https://orcid.org/0000-0001-6200-9578
Benigni, Fabio
Noack, Julia
Park, Young-Jun https://orcid.org/0000-0003-2901-6949
Bianchi, Siro https://orcid.org/0000-0002-5100-8905
Walls, Alexandra C. https://orcid.org/0000-0002-9636-8330
Bowen, John E. https://orcid.org/0000-0003-3590-9727
Zhou, Jiayi https://orcid.org/0000-0002-4231-3422
Kaiser, Hannah https://orcid.org/0000-0002-3991-7401
Joshi, Anshu
Agostini, Maria
Meury, Marcel
Dellota, Exequiel Jr
Jaconi, Stefano https://orcid.org/0000-0001-7527-4434
Cameroni, Elisabetta
Martinez-Picado, Javier https://orcid.org/0000-0002-4916-2129
Vergara-Alert, Júlia
Izquierdo-Useros, Nuria
Virgin, Herbert W. https://orcid.org/0000-0001-8580-7628
Lanzavecchia, Antonio https://orcid.org/0000-0002-3041-7240
Veesler, David https://orcid.org/0000-0002-6019-8675
Purcell, Lisa A.
Telenti, Amalio https://orcid.org/0000-0001-6290-7677
Corti, Davide https://orcid.org/0000-0002-5797-1364
- License Information
-
More Information
Article History
Received: 3 April 2021
Accepted: 18 August 2021
First Online: 31 August 2021
Competing interests
: F.A.L., L.S., F.B., S.B., M.M.-R., J.N., J.Z., H.K., M.A., M.M., E.D., S.J., E.C., H.W.V., A.L., L.P., A.T. and D.C. are employees of Vir Biotechnology and may hold shares in Vir Biotechnology. H.W.V. is a founder of PierianDx and Casma Therapeutics. L.P. is a former employee and shareholder in Regeneron Pharmaceuticals. Neither company provided funding for this work or is performing related work. D.V. is a consultant for Vir Biotechnology. The laboratory of D.V. has received a sponsored research agreement from Vir Biotechnology. A patent application related to SIGLEC1 and SARS-CoV-2 recognition has been filed by IrsiCaixa (US 63/152,346). J.M.-P. reports institutional grants and educational and consultancy fees from AbiVax, Astra-Zeneca, Gilead Sciences, Grifols, Janssen, Merck and ViiV Healthcare. N.I.-U. reports institutional grants from Pharma Mar, Dentaid and Palobiofarma. The remaining authors declare no competing interests.
Free to read: This content has been made available to all.
